» Articles » PMID: 38236345

Alterations of MRNAs and Non-coding RNAs Associated with Neuroinflammation in Alzheimer's Disease

Abstract

Alzheimer's disease is a neurodegenerative pathology whose pathognomonic hallmarks are increased generation of β-amyloid (Aβ) peptide, production of hyperphosphorylated (pTau), and neuroinflammation. The last is an alteration closely related to the progression of AD and although it is present in multiple neurodegenerative diseases, the pathophysiological events that characterize neuroinflammatory processes vary depending on the disease. In this article, we focus on mRNA and non-coding RNA alterations as part of the pathophysiological events characteristic of neuroinflammation in AD and the influence of these alterations on the course of the disease through interaction with multiple RNAs related to the generation of Aβ, pTau, and neuroinflammation itself.

Citing Articles

Recent advances of PIWI-interacting RNA in cardiovascular diseases.

Li B, Wang K, Cheng W, Fang B, Li Y, Yang S Clin Transl Med. 2024; 14(8):e1770.

PMID: 39083321 PMC: 11290350. DOI: 10.1002/ctm2.1770.


Exploring the Roles of Key Mediators IKBKE and HSPA1A in Alzheimer's Disease and Hepatocellular Carcinoma through Bioinformatics Analysis.

Wang Y, Yang Y, Liang C, Zhang H Int J Mol Sci. 2024; 25(13).

PMID: 39000042 PMC: 11241202. DOI: 10.3390/ijms25136934.


Investigating the potential neuroprotective benefits of taurine and Dihydrotestosterone and Hydroxyprogesterone levels in SH-SY5Y cells.

Almohaimeed H, Almars A, Alsulaimani F, Basri A, Althobaiti N, Albalaw A Front Aging Neurosci. 2024; 16:1379431.

PMID: 38867846 PMC: 11168113. DOI: 10.3389/fnagi.2024.1379431.

References
1.
Bai B, Vanderwall D, Li Y, Wang X, Poudel S, Wang H . Proteomic landscape of Alzheimer's Disease: novel insights into pathogenesis and biomarker discovery. Mol Neurodegener. 2021; 16(1):55. PMC: 8359598. DOI: 10.1186/s13024-021-00474-z. View

2.
Bondi M, Edmonds E, Salmon D . Alzheimer's Disease: Past, Present, and Future. J Int Neuropsychol Soc. 2017; 23(9-10):818-831. PMC: 5830188. DOI: 10.1017/S135561771700100X. View

3.
Hoogmartens J, Cacace R, Van Broeckhoven C . Insight into the genetic etiology of Alzheimer's disease: A comprehensive review of the role of rare variants. Alzheimers Dement (Amst). 2021; 13(1):e12155. PMC: 7896636. DOI: 10.1002/dad2.12155. View

4.
Knopman D, Amieva H, Petersen R, Chetelat G, Holtzman D, Hyman B . Alzheimer disease. Nat Rev Dis Primers. 2021; 7(1):33. PMC: 8574196. DOI: 10.1038/s41572-021-00269-y. View

5.
Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chetelat G, Teunissen C . Alzheimer's disease. Lancet. 2021; 397(10284):1577-1590. PMC: 8354300. DOI: 10.1016/S0140-6736(20)32205-4. View